» Articles » PMID: 38613686

The Boon and Bane of Nitrous Oxide

Overview
Specialties Neurology
Psychiatry
Date 2024 Apr 13
PMID 38613686
Authors
Affiliations
Soon will be listed here.
Abstract

Nitrous oxide (N2O) has been known since the end of the eighteenth century. Today, N2O plays a huge role as a greenhouse gas and an ozone-depleting stratospheric molecule. The main sources of anthropogenic N2O emissions are agriculture, fuel combustion, wastewater treatment, and various industrial processes. By contrast, the contribution of medical N2O to the greenhouse effect appears to be small. The recreational and medical uses of N2O gradually diverged over time. N2O has analgesic and anesthetic effects, making it widely used in modern dentistry and surgery. New research has also begun studying N2O's antidepressant actions. N-methyl-D-aspartate (NMDA) antagonism and opioid effects are believed to be the main underlying biochemical mechanisms. At this point, numerous questions remain open and, in particular, the conduct of larger clinical trials will be essential to confirm N2O's use as a rapid-acting antidepressant. The N2O concentration delivered, the duration of a single inhalation, as well as the number of inhalations ultimately required, deserve to be better understood. Finally, the non-medical use of N2O has gained significant attention in recent years. Sudden deaths directly attributed to N2O are primarily due to asphyxia. Heavy, chronic N2O use may result in vitamin B12 deficiency, which, among other things, may cause megaloblastic anemia, venous thrombosis, myeloneuropathy, and skin pigmentation. Helpful biochemical tests include homocysteine and methylmalonic acid. The centerpiece of treatment is complete cessation of N2O use together with parenteral administration of vitamin B12.

Citing Articles

[The use of nitrous oxide (laughing gas) is no joking matter].

Kronenberg G, Provaznikova B, Schoretsanitis G, Monn A, Seifritz E, Olbrich S Nervenarzt. 2025; .

PMID: 39945799 DOI: 10.1007/s00115-025-01810-0.


Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression.

Freudenberg F, Reif-Leonhard C, Reif A Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39207462 DOI: 10.1007/s00406-024-01875-z.

References
1.
Back S, Kroon E, Colyer-Patel K, Cousijn J . Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users. Addiction. 2023; 119(4):609-618. DOI: 10.1111/add.16380. View

2.
Banjongjit A, Sutamnartpong P, Mahanupap P, Phanachet P, Thanakitcharu S . Nitrous Oxide-Induced Cerebral Venous Thrombosis: A Case Report, Potential Mechanisms, and Literature Review. Cureus. 2023; 15(7):e41428. PMC: 10403680. DOI: 10.7759/cureus.41428. View

3.
Barbosa L, Leal I, Timoteo A, Matias T . [Acute megaloblastic anemia caused by inhalation of nitrous oxide in a patient with multiple autoimmune pathology]. Acta Med Port. 2001; 13(5-6):309-12. View

4.
Becker D, Rosenberg M . Nitrous oxide and the inhalation anesthetics. Anesth Prog. 2008; 55(4):124-30. PMC: 2614651. DOI: 10.2344/0003-3006-55.4.124. View

5.
Berkowitz B, NGAI S, Finck A . Nitrous oxide "analgesia": resemblance to opiate action. Science. 1976; 194(4268):967-8. DOI: 10.1126/science.982058. View